Clorox Co (CLX Stock) may rise after four down days, coronavirus is key

NYSE: CLX has shed around 5% in four days, and could bounce back.
Rising COVID-19 cases in the US could bring people indoors and increase the consumption of Clorox's products.
The firm's new management enjoys credit from investors.

Coronavirus is a dominant theme for markets – stocks have risen on hopes for a new relief bill and dropped as pessimism about talks in Capitol Hill diminished. Clorox Co (NYSE: CLX) has mostly been moving with the broader mood. On Monday, the S&P 500 fell by 1.63% and CLX shed some 1.22%.

However, every crisis also presents opportunities. Clorox produces a wide range of products consumed at home – and the pandemic means more people are staying indoors. COVID-19 infections are surging in Europe and have already resulted in restrictions in various countries and regions, yet little attention has been paid to Clorox's home market.

As temperatures fall, cases are rising, especially in colder states like Wisconsin, Minnesota, and Illinois, but figures are advancing elsewhere. Even if governors refrain from imminent action to prevent social gatherings, more people are likely to work from home or keep their children away from school whenever possible.

Infections are rising in early autumn and the situation could further worsen as winter arrives. More time at home implies more demand for cleaning and other products, potentially boosting Clorox's sales and its stock price.

Another reason to be bullish on CLX is its new management. Linda Rendle has assumed the position of CEO a month ago, and still enjoys a "honeymoon" from investors. Moreover, as the new boss, she could make internal reorganization that would make Clorox more profitable.

CLX Stock Price

NYSE: CLX has been falling for four consecutive days, shedding nearly $10 and almost 5% from its closing peak of $221.17 on October 13. Critical support awaits at $209.11, which is the lowest point in October. The initial upside target is $215.13, a swing high from last week.

Share: Feed news

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.

If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.

FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.

The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.